The Health (Miscellaneous Provisions) Bill will amend the Health Act, 1970, the Tobacco (Health Promotion and Protection) Act, 1988 and the Health (Nursing Homes) Act, 1990. In brief, this composite Bill sets out the Government's proposals to improve and update the statutory basis for the supply of drugs, medicines and medical and surgical appliances under the general medical services and community drugs schemes; to raise the age at which tobacco products can be sold to young persons from the present age of 16 years to 18 years and to raise the maximum fine on persons convicted for selling tobacco products to under age persons from £500 to £1,500; to empower the Minister for Health and Children to prescribe any necessary administrative and technical details to facilitate the efficient administration of the scheme for the payment of subvention in respect of patients in nursing homes and also to empower the Minister to make regulations governing standards in private convalescent homes under the Health (Nursing Homes) Act, 1990.
For reasons of clarity, as this is a composite Bill, I propose to speak about each of the three distinct elements of the Bill and then to outline the detailed contents of the Bill as a whole.
My purpose in amending section 59 of the Health Act, 1970, is threefold. In essence, section 59 is the statutory basis for the supply of drugs, medicines and medical and surgical appliances under the general medical services and the community drugs schemes, the schemes which allow the reimbursement by the State of medicines taken by patients in the community. As the legislation is 30 years old and the increasingly complex pharmaceutical issues facing us in this millennium could not have been foreseen when the Health Act, 1970, was drafted, it has been necessary to review the legislation with a view to improving and updating the regulation of the supply of drugs, medicines and medical and surgical appliances under the general medical services and community drugs schemes, promoting an equitable and more accountable service in this regard and making better provision for the delivery of community pharmacy services.
Under present arrangements, drugs, medicines and medical and surgical appliances are provided without charge to persons with full eligibility, that is, medical card holders, in line with criteria for reimbursement. Traditionally, these items are supplied through community pharmacies or, in cases where there is no local pharmacy, by the patient's general practitioner who in these circumstances is known colloquially as a dispensing doctor.
The position with regard to the provision of drugs, medicines and medical and surgical appliances for persons with limited eligibility – non-medical card holders – is that community drugs schemes have been in operation over the years whereby the State meets a proportion of the cost of prescribed products. Under the current scheme, the drug payment scheme, an individual or family pays the first £42 in respect of expenditure on approved prescribed drugs, medicines and medical and surgical appliances and the balance of the cost is met by the State.
A third arrangement, known as the long-term illness scheme, is in place for persons suffering from a prescribed disease or disability of a permanent or long-term nature whereby drugs are made available without charge in respect of the treatment of the primary condition.
The provisions of the Bill will continue present arrangements and, as in the current situation, drugs will be supplied without charge to persons with full eligibility and expenditure incurred by persons with limited eligibility in respect of themselves or their dependants will be recouped in part, as prescribed by regulation. Broadly speaking, "dependants" is defined as spouse, children under the age of 18 years or under 23 years if in full-time education, or children of any age with a mental or physical disability to the extent that it is not reasonably possible for the child to maintain himself or herself fully and who are living at home. The crucial or pivotal point with regard to a scheme such as the drug payment scheme, as is borne out by the definition of dependants, is that it is not means tested and is open to everyone. The Bill also continues to provide for the long-term illness scheme.
My concerns are to ensure that arrangements for the supply of drugs, medicines and medical and surgical appliances in the community are equitable, all arrangements meet accountability requirements and the service to patients is a quality service. Section 59 of the Health Act, 1970, does not facilitate a clear and transparent approach to reimbursement, does not explicitly provide for accountability and is not adequately structured to promote a quality driven community pharmacy service. In other words, time and expectations have moved on but the legislation underpinning the supply of drugs, medicines and medical and surgical appliances has not. Steps must therefore be taken to bring the legislation into line with current demands and requirements.
The Bill provides for the making of regulations concerning the granting of approval of drugs, medicines and medical and surgical appliances for reimbursement purposes and the withdrawal of this approval for stated reasons. This will ensure an equitable, transparent and coherent approach to reimbursement. As I mentioned earlier, section 59 of the Health Act, 1970, is concerned with the supply of drugs, medicines and medical and surgical appliances in the community. The Bill therefore provides for the supply of reimbursable products through community pharmacies as the most appropriate dispensing arrangement in most instances for medicines taken in the community. This reflects current practice and policy regarding the provision of community pharmaceutical care in line with the contractor agreement for the provision of community pharmacy services under the Health Act, 1970, which was introduced in 1996 and which is pro-active in promoting a quality driven service to the patient.
I have no doubt that the service to patients has been enhanced as a result of the new contractor agreement which imposes obligations not in place before. A central and innovative element of the contractor agreement is a clause providing for a review by the pharmacist of the medicine therapy of the patient, including screening for any potential drug therapy problems, therapeutic duplication, drug to drug interactions, incorrect drug dosage or duration of drug treatment, drug allergy interactions and clinical abuse or misuse. The review also includes an examination of the rational and cost effective use of the medicine prescribed, including the choice of medicines and the potential for wastage. In addition, the contractor agreement is designed to improve the quality of services by encouraging greater investment in the pharmacy and facilitating the involvement of a greater number of pharmacists in a given pharmacy.
In this context, the Bill makes specific provision for the making of regulations in regard to agreements between the proprietor of a community pharmacy and a health board pursuant to which community pharmacies supply drugs and medicines and medical and surgical appliances under the general medical services and community drugs schemes designed to foster the best possible community pharmacy service. However, the Bill also takes account of the fact that, in the absence of a community pharmacy service, some medical card patients in remote areas will rely on their general practitioners, dispensing doctors, for the supply of medicines.
In addition, the provisions of the Bill acknowledge the dramatic pharmaceutical advancements which have taken place in recent years and which are likely to continue, perhaps at an even faster pace. In some circumstances, it may be appropriate for patient safety and monitoring purposes for certain sophisticated drugs to be dispensed in a hospital or clinic setting on an out-patient basis. The Bill, therefore, provides for the reimbursement of products provided by an institution that provides a specialist service under the direct supervision of a medical consultant, where approved by the Minister in accordance with regulations.
In terms of supply and value for money, and in some cases patient convenience, it is recognised that community pharmacies may not be the most appropiate source of some non-drug items and that expertise in this area may lie elsewhere. On this basis, the Bill will also allow the reimbursement of some non-drug items supplied through other outlets approved by the Minister in accordance with regulations.
From the point of view of value for money and accountability, the Bill will empower the Minister to make regulations to provide for the manner in which payments to community pharmacists and others who supply items under section 59 of the Health Act, 1970, are made by the relevant State agencies with responsibility in this matter and for the furnishing of information on items supplied, services provided and the costs involved. Regulations may also be made for the furnishing of information the relevant State agencies may require by suppliers of drugs, medicines and medical and surgical appliances to those dispensing these products. The Bill, therefore, provides a good legislative basis for verification of claims on the State by those supplying products reimbursable by the State.
I will return to the amendment of section 59 of the Health Act, 1970, when outlining the contents of the Bill but I now move on to the amendment of the Health (Promotion and Protection) Act, 1988.
I regard the battle against smoking as one of the most important public health challenges facing us in the new millennium and this area is one of my main priorities as Minster for Health and Children. The adverse impact of tobacco consumption on public health is enormous. Smoking-related illnesses account for about 7,000 deaths each year in Ireland. Within the European Union the tobacco epidemic is killing over half a million citizens each year.
Work is under way in my Department to prepare a new comprehensive tobacco Bill which will take on board a range of issues relating to tobacco and health. I hope to have this Bill ready for the autumn session. I am particularly concerned by the reported increase in the level of smoking among children and teenagers. One of the most disturbing facts about smoking is that for the vast majority of smokers the addiction begins in their childhood or teenage years. The tobacco industry has targeted children in their marketing campaigns and has sought to get them hooked at an early age. The sale of tobacco products to children and under age persons in particular is a most reprehensible practice and is one that has to be tackled aggressively.
The report, Towards a Tobacco Free Society, launched by me on 7 March this year recommends, among other things, raising the age limit at which tobacco products can be sold to young persons to 18 years, as does the report of the Joint Committee on Health and Children on smoking and health, published in November 1999.
The proposed amendment to the Tobacco (Health Promotion and Protection) Act, 1988, before the House today will have the effect of raising the age at which tobacco products can be sold to young persons from 16 to 18 years and will raise the maximum fine on persons convicted of selling to under age persons from £500 to £1,500. The increase in the maximum fine to £1,500 is the highest amount that can be included in this type of amendment and will act as a further deterrent to retailers. I take this measure on legal advice.
Section 3 of the Bill amends the Health (Nursing Homes) Act, 1990. This Act, which came into effect on 1 September, 1993 has two principal objectives. The first is to ensure high standards of accommodation and care in all nursing homes registered under the Act and the second is to provide a system of subventions for dependent persons in need of nursing home care.
With regard to subventions, section 7(2) of the Act provides that the Minister may by regulations prescribe the amounts of subvention that may be paid, and such amounts may be specified by reference to specified degrees of dependency, specified means or circumstances of dependent per sons or such other matters as the Minister considers appropriate.
The rates of subvention were duly specified in the Nursing Homes (Subvention) Regulations, 1993 (S.I. No. 227 of 1993). In order to facilitate the operation of the subvention scheme, provisions relating to the administration of the scheme are required. These provisions would cover areas such as making of applications for subvention; onus on the applicant to furnish infomation; assessment of degree of dependency; assessment of means and circumstances; calculation of amounts payable; notification of decision on applicants; review of subventions decision; death or discharge of patient; services to be covered by subvention; appeals against decisions; and recoupment of subventions.
It is proposed, therefore, to amend section 7(2) to provide the powers to prescribe any necessary administrative and technical details. In addition, a further amendment of the Act is required to take account of the introduction by the Minister for Finance of a scheme of tax allowances in respect of capital expenditure on private convalescent homes in the Finance Act, 1999. The allowances apply to expenditure incurred on or after 2 December 1998 on the construction, extension or refurbishment of a convalescent home as well as the conversion of an existing building into a convalescent home. To ensure that the standard of care in convalescent homes is satisfactory, it is proposed that such homes be required to be registered under the Health (Nursing Homes) Act, 1990.
Regulations have been made under section 6 of the Act for the purpose of ensuring proper standards in nursing homes. It will be necessary to make similar regulations governing standards in convalescent homes, which may include provisions requiring convalescent homes to have adequate medical, nursing and para-medical staff and facilities, consistent with the patient profile of the home. I propose to amend section 6 of the Act to give ministerial power to prescribe different requirements for such homes.
I will now outline some of the contents of the Bill. Section 1 amends section 59 of the Health Act, 1970, by the substitution of a new section for the existing section. Section 1(1), (2) and (3) provides for the supply of approved, prescribed drugs, medicines and medical and surgical appliances to people with full eligibility and people with limited eligibility and their dependants.
Section 1(4) provides for the supply of approved, prescribed medicines to medical card holders by dispensing doctors and also for the supply of non-drug items to people with full eligibility and limited eligibility by other persons as approved by the Minister. Section 1(5) provides for the supply of approved, prescribed drugs by an institution that provides a specialist service under the direct supervision of a medical consultant and stands approved by the Minister. Section 1(6) provides for the making of regulations specifying the terms and conditions upon which and the extent to which health boards may defray the cost of supplying a particular drug or drugs or drugs for the treatment of a particular condition or conditions.
Section 1(7) provides for the granting of an approval by the Minister for the purposes of the previous subsections and for the withdrawal of an approval for stated reasons and in accordance with regulations. Section 1(8) is a standard provision to the effect that the Minister may make regulations for the purposes of this section.
Section 1(9) provides that regulations may provide for the manner in which payments may be made in respect of drugs supplied by community pharmacies and persons referred to in section 1(4) and (5) and in respect of fees for services. The regulations may also provide for the furnishing of information required on drugs supplied and services provided and for the refusal of payment if a request for information is not complied with.
Section 1(10) provides for regulations in relation to agreements between the proprietors of pharmacies and health boards pursuant to which community pharmacies supply drugs for the purpose of this section. Section 1(11) provides that where a supplier of drugs to community pharmacies fails or refuses to comply with a request under regulations, the supplier shall be guilty of an offence and liable to summary conviction to a fine not exceeding £1,500. Section 1(12)(1) is a standard subsection defining words or phrases in the section. Section 1(12)(2) is a standard provision for regulations made under section 59 of the Health Act, 1970.
Section 2 amends the Tobacco (Health Promotion and Protection) Act, 1988, by substituting a new section for section 3 of that Act to raise the age at which tobacco products can be sold to young persons from the present age of 16 years to 18 years and to raise the maximum fine on persons convicted for selling tobacco products to under age persons from £500 to £1,500. It also provides that it shall be a defence for a person who is prosecuted for an offence under this section to establish that he or she had taken all reasonable steps to assure himself or herself that the person to whom the tobacco products were sold, offered for sale or made available had attained the age of 18 years.
Section 3 amends the Health (Nursing Homes) Act, 1990, by the insertion of a new subsection after subsection (6) of the Health (Nursing Homes) Act, 1990, to provide for regulations to make different provision for different classes of nursing homes and prescribe different requirements for different classes of nursing homes. In section 7 of the Act a new subsection is substituted for subsection (2) in regard to the making of regulations prescribing any necessary administrative and technical details in relation to the operation of the subvention scheme.
Section 4 is a standard technical provision setting out the title of the Bill and providing that it and the Health Acts, 1947 to 1999, may be cited together as the Health Acts, 1947 to 2000, and that the Tobacco (Health Promotion and Protection) Act, 1988, and this Act may be cited together as the Tobacco (Health Promotion and Protection) Acts, 1988 and 2000. It also provides for the making of orders in regard to the coming into operation of the provisions of the Bill.
These are the provisions of the Bill. I know everyone in this House is committed to fair and transparent arrangements for the supply of drugs, medicines and medical and surgical appliances under the Health Act, 1970. There can be no doubt that the House is committed to appropriate anti-tobacco strategies in view of the effects of tobacco on the nation's health. I am sure there is commitment to necessary changes in the Health (Nursing Homes) Act, 1990. The Bill contains a range of measures in regard to its three distinct elements to strengthen and underpin existing legislation. We are prepared to listen to the debate and will consider any amendments which Senators table on Committee Stage with a view to bolstering the provisions of the Bill.
I commend the Bill to the House.